Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by sollmgon Jan 24, 2019 2:45pm

231 Views

Post# 29277145

RE:RE:RE:RE:RE:if management are quiet maybe maybe something is finally

sollmg wrote: According to the Stockwatch records, Canaccord has sold 8,597,600 shares on behalf of PLI under the ATM for a fund raise of $3,014,149.00. Any dilution over the next two months will be irrelevent once the do an IPO on the NASDAQ.

I should have added that the 8,597,600 shares sold is only Jan 19. Stockwatch has them selling 3,958,656 shares in Dec 18 for $1,333,263.

Bullboard Posts

Canadian artificial intelligence ETFs